pennews
www.pennews.net
Dr Reddy’s launches OTC store brand in US Market
Business

Dr Reddy’s launches OTC store brand in US Market

Agency News

Hyderabad, Jul 9 : Dr Reddy’s Laboratories along with its subsidiaries together on Tuesday announced the launch of an over-the-counter (OTC) store-brand equivalent of Mucinex D Extended Release Tablets, Guaifenesin and Pseudoephedrine HCl .

Company plans to launch these tablets in two strengths—Guaifenesin 600 mg and Pseudoephedrine HCl 60 mg, and Guaifenesin 1200 mg and Pseudoephedrine HCl 120 mg—in the United States market, as approved by the US Food and Drug Administration (USFDA).

Dr Reddy’s OTC Guaifenesin and Pseudoephedrine HCl is used to help loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive, temporarily relieve nasal congestion due to common cold, hay fever, and upper respiratory allergies, temporarily restores freer breathing through the nose, promotes nasal and/or sinus drainage, and temporarily relieves sinus congestion and pressure, a company statement here said.

"We are excited to bring first to market the store-brand equivalent of Mucinex D Maximum Strength Extended Release Tablets. These launches illustrate our continued commitment to the OTC business and our growing portfolio in the cough, cold and allergy category,” said Milan Kalawadia, Senior Vice President and Head of US OTC and Specialty Rx Divisions, Dr Reddy’s Laboratories.

The Mucinex D brand and store brands had combined U S sales of approximately USD 71 million MAT for the most recent twelve months ending in May 2019 according to IRI. Dr Reddy’s OTC Guaifenesin 1,200 mg and Pseudoephedrine HCl 120 mg is available in 24-count packages.

Dr Reddy’s OTC Guaifenesin 600 mg and Pseudoephedrine HCl 60 mg is available in 18- and 36-count packages, the statement added. (UNI)